VR Logo

PureTech Health plc (PRTC) download report


Healthcare | Biotechnology & Pharma Research

PureTech Health plc (PRTC) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States.

IPO Date: 16-Nov-2020

Founder, CEO & Exec. Director: Ms. Daphne Zohar

Co-Founder & Board Advisor: Dr. Bennett M. Shapiro M.D.

Listing: NASDAQ: PRTC

Country: United States

Headquarters: Boston, MA

Website: https://www.puretechhealth.com

Key Facts

Market cap: $618.53 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-60.56 Mln

Cash: $465.71 Mln

Total Debt: $0.00 Mln

Insider's Holding: 0.01%

Liquidity: Low

52 Week range: $18.15 - 56.46

Shares outstanding: 28,742,100

10 Years Aggregate:

  • CFO: $-657.15 Mln
  • EBITDA: $387.69 Mln
  • Net Profit: $208.60 Mln

Stock Performance

Time Period PureTech Health (PRTC) S&P BSE Sensex S&P Small-Cap 600
YTD-42.78-8.99-19.23
1 month-9.53-3.40-9.35
3 months-21.21-8.50-16.59
1 Year-56.190.89-17.36
3 Years--10.415.90
5 Years--11.435.77
10 Years--11.779.78
As on 30-Jun-2022
Year PureTech Health (PRTC) S&P Small-Cap 600 S&P BSE Sensex
2021-31.4825.2721.99